丹栀逍遥散对D-氨基半乳糖/脂多糖诱导的大鼠急性肝损伤保护作用机制研究*

doi:10.3969/j.issn.1672-5069.2022.02.007

Abstract

Abstract: Objective The aim of this study was to explore the protective mechanism of Danzhi Xiaoyao powder on hepatic damage in rats with D-galactosamine (D-GaIN)/lipopolysaccharide (LPS)-induced acute liver injury (ALI). Methods 110 SD male rats were randomly divided into control, model, low-dose, moderate dose and large-dose of herbal medicine-intervened groups, with 22 rats in each. The ALI model was built-up by D-GaIN/LPS injection intraperitoneally, and the herbal medicine was given by lavage. Serum MDA, SOD, GSH-PX, IL-6, IL-1β, TNF-α levels were detected by ELISA, and serum HA, LN and Ⅲ-PC levels were assayed by RIA. Results Serum AST, ALT, bilirubin and MDA levels in model group were (12081.3±587.7)U/L, (7658.7±742.2)U/L, (104.3±10.3)μmol/L and (8.9±1.1)mmol/mL, all significantly higher than [(171.9±17.2)U/L, (60.5±6.2)U/L, (2.4±0.2)μmol/L and (2.5±0.3)mmol/mL, respectively, P＜0.05] in the control; serum SOD and GSH-PX levels were (14.3±1.7)U/mL and (7.1±0.7)μmol/L, both significantly lower than [(38.6±4.4)U/mL and (21.9±2.2)μmol/L, P＜0.05] in the control, while serum SOD and GSH-PX levels in three herbal medicine-intervened groups significantly higher than those in the model (P＜0.05); serum IL-6, IL-1β and TNF-α levels in the model were (194.3±20.5)ng/mL, (24.7±2.5)ng/ml and (864.5±87.3)ng/mL, significantly higher than [(90.1±10.3)ng/mL, (5.2±1.0)ng/mL and (30.2±4.1)ng/mL in the control, while all significantly decreased compared to those in the model in three herbal medicine-intervened groups (P＜0.05); serum HA, LN and Ⅲ-PC levels were (286.3±29.1)ng/ml, (297.4±30.5)ng/ml and (257.1±26.7)ng/ml, all significantly higher than [(55.1±6.2)ng/mL, (75.1±7.6)ng/mL and (61.9±6.2)ng/mL] in the control, while all significantly decreased compared to those in the model in three-herbal medicine-intervened groups(P＜0.05). Conclusion Danzhi Xiaoyao powder could exert significant protective effect on liver functions in rats with D-GaIN/LPS-induced ALI, and the mechanism by which it works might be related to obvious inhibition of oxidative stress and inflammation response.

Key words: Acute liver injury, Danzhi Xiaoyao powder, herbal medicine, Galactosamine, Lipopolysaccharide, Rats

Liu Shangzhi, Zhang Zhiqiang, Li Shengjin. Protective mechanism of Danzhi Xiaoyao powder on hepatic damage in rats with D-galactosamine/lipopolysaccharides-induced acute liver injury[J]. Journal of Practical Hepatology, 2022, 25(2): 179-182.

References

[1] Koda Y , Nakamoto N , Chu P S , et al. Plasmacytoid dendrtic cells protect againstacute liver injury via IL-35. J Hepatol, 2020, 73(34):565-566.
[2] Fernando H, Bessone GS, Mercedes AH, et al. Assessment of serious acute and chronic idiosyncratic drug-induced liver injury in clinical practice. Semi Liver Dis, 2019,24(319)41-43.
[3] 王伟斌, 李敬华, 于琦,等. 基于古代医案的郁证用药规律分析. 中国实验方剂学杂志, 2020, 26(5):170-175.
[4] Li W , Yan L , Can Y , et al. Antidepressant-like effects of fractions prepared from danzhi-xiaoyao-san decoction in rats with chronic unpredictable mild stress: effects on hypothalamic-pituitary-adrenal axis, arginine vasopressin, and neurotransmitters. Evid Based Complement Altern Med, 2016, 31(20), 1-11.
[5] 王宝香, 刘盼, 丁艳,等. 大黄素对小鼠急性肝损伤过程中Toll样受体4表达的影响及其机制. 中华肝脏病杂志, 2020, 28(1):73-76.
[6] 王艳, 黄小平, 甘建和. 抗菌肽Cathelicidin-PY治疗急性肝衰竭小鼠的初步研究. 中华肝脏病杂志, 2020, 28(3):254-258.
[7] 高有曼, 李瑞芳, 高子涵,等. 柴胡皂苷b-2对LPS/GalN诱导的小鼠急性肝损伤炎症和能量代谢的影响. 中国中药杂志, 2019, 15(26):41-43.
[8] Wang X , Yan S , Xu D , et al. Aggravated liver injury but attenuated inflammation in PTPRO-deficient mice following LPS/D-GaIN induced fulminant hepatitis. Cell Physiol Biochem, 2015, 37(1):214-224.
[9] Lyu H , An B , Yu Q , et al. The hepatoprotective effect of myricetin against lipopolysaccharide and D-galactosamine-induced fulminant hepatitis. Int J Biol Macromol, 2020, 15(155):1092-1104.
[10] 朱昕玥, 彭海燕. 丹栀逍遥散化裁治验四则. 中华中医药杂志, 2013, 28(7):2047-2049.
[11] A Z P , A X G , B Y Y , et al. Hepatoprotective effect of quercetin against LPS/d-GalN induced acute liver injury in mice by inhibiting the IKK/NF-κB and MAPK signal pathways. Sci Direct Int Immu, 2017, 52(24):281-289.
[12] Sharanek A , Burban A , Ciriaci N , et al. Pro-inflammatory cytokines enhance dilatation of bile canaliculi caused by cholestatic antibiotics. Toxicol In Vitro, 2019, 58(24):51-59.
[13] Joshua H, Stover JS, Niloofar BE, et al. Multiplex epigenome editing of drg neuron receptors abolishes redundant IL-6, TNF-α, and IL-1β signaling by the degenerative IVD.Hum Gene Ther, 2019, 19(24):1214-1216.
[14] Zhang Y , Li Y , Li J , et al. SIRT1 alleviates isoniazid-induced hepatocyte injury by reducing histone acetylation in the IL-6 promoter region. Int Immunopharmacol, 2019, 67:348-355.
[15] 田玉伟, 杨国威, 薛焕洲, 等. 雷帕霉素对氨基半乳糖/脂多糖诱导急性肝损伤小鼠保护作用及其机制. 中华实验外科杂志, 2018, 35(2):253-256.
[16] Han C , Wei Y , Wang X , et al. Protective effect of salvia miltiorrhiza polysaccharides on liver injury in chickens. Poul Sci, 2019, 98(9):3496-3503.
[17] 江利敏, 刘向哲. 丹栀逍遥散加减治疗卒中后抑郁的疗效及作用机制. 中国实验方剂学杂志, 2019, 25(3):116-121.
[18] 杨益萍, 白钰, 马凤岐, 等. 古代医籍泄泻医案用药规律的发掘研究. 中华中医药杂志, 2019, 25(3):116-121.
[19] Zhu H Z , Liang Y D , Ma Q Y , et al. Xiaoyaosan improves depressive-like behavior in rats with chronic immobilization stress through modulation of the gut microbiota. Biomed Pharmacother, 2019, 112(35):108-110.
[20] 韦凌霞, 丁茂鹏, 王志旺, 等. 基于数据挖掘及网络药理学方法探讨含当归中药复方抗肝纤维化的用药规律及作用机制. 中药新药与临床药理, 2020, 31(11):65-73.

Protective mechanism of Danzhi Xiaoyao powder on hepatic damage in rats with D-galactosamine/lipopolysaccharides-induced acute liver injury

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Yin Tianquan, Zhao Cheng, Liu Yan. Efficacy of Shenfu injection in treatment of patients with acute liver injury and sepsis [J]. Journal of Practical Hepatology, 2022, 25(2): 295-296.
[2]	Shi Xueli, Zhang Wanli, Mao Jun. Serum IL-38 and β2GPI levels in rats with autoimmune hepatitis and their relationship with liver tissue lesions [J]. Journal of Practical Hepatology, 2021, 24(6): 803-806.
[3]	Gu Xuexiang, Li Xiangyu, Shan Qinxing. Protective effect of saikosaponin A on hepatic steatosis in rats with non-alcoholic fatty liver disease by affecting PPARα signaling pathway [J]. Journal of Practical Hepatology, 2021, 24(6): 807-810.
[4]	Xu Xiangtao, Qiao Fei, Che Junyong, et al. Short-term efficacy of Huazhuo Tongyu decoction in the treatment of patients with non-alcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(5): 701-704.
[5]	Guan Haiyan, Yang Wenbin. Clinical features and prognosis of patients with drug-induced liver injury [J]. Journal of Practical Hepatology, 2021, 24(5): 713-716.
[6]	Liu Na, Zhang Huamin, Deng Qiaojuan. Impact of inhibition of TRAF6 gene expression on hepatic NF-κB-related protein expression in rats with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2021, 24(4): 468-471.
[7]	Dang Ling, Jia Ai, Wang Fang. Prognosis of patients with subacute liver failure by serumlipopolysaccharide binding protein and sCD163 levels [J]. Journal of Practical Hepatology, 2021, 24(3): 447-448.
[8]	Rong Haifang, Wang Liguo. Establishment of hepatopulmonary syndrome induced by common bile duct ligation in rats [J]. Journal of Practical Hepatology, 2021, 24(2): 176-179.
[9]	Su Qihao, Ren Limei, Jiang Fengxia, et al. Protective effect of Mongolian medicine Erligen II on liver fibrosis in rats [J]. Journal of Practical Hepatology, 2021, 24(2): 180-183.
[10]	Rong Aimei,Zhang Chao,Wu Huili. Effect of sirolimus on peripheral blood Treg/Th17 cell ratio in high fat diet-induced NAFLD in rats [J]. Journal of Practical Hepatology, 2021, 24(1): 10-13.
[11]	Li Wei, Guo Chunxia, Liu Sunan. Increasedliver regeneration and liver tissue NK cell cytoxicity by resveratrol stimulus in rats with partial hepatectomy [J]. Journal of Practical Hepatology, 2020, 23(6): 785-788.
[12]	Wang Yu, Wang Nan, Wang Qiaoxia, et al. Liganlong and magnesium isoglycyrrhizate combination mitigates liver injury via inhibiting humoral immunity in patients with autoimmune hepatitis [J]. Journal of Practical Hepatology, 2020, 23(6): 821-824.
[13]	Wang Yu, Wang Nan, Liu Yuanyuan, et al.. Effects of herbacetin onhepatic steatosis and intrahepatic oxidative stress in rats with non-alcoholic steatohepatitis [J]. Journal of Practical Hepatology, 2020, 23(5): 626-629.
[14]	Lu Yongyu, Liu Changjiang, Huang Shuai.. Very short-term efficacy of silybin meglumine and Danning tablet combination in treatment of patients with alcoholic hepatitis [J]. Journal of Practical Hepatology, 2020, 23(5): 662-665.
[15]	Xing Xiaoyan,Huang Liangmiao, Fu Aixian,et al.. Short-term observation of yinzhihuang and adenosine methionine in treatment of patients withintrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2020, 23(5): 670-673.